To take on the coronavirus, US vaccine makers consider an unprecedented strategy: working together

One approach is more typical, and involves each company working independently on its own trial, according to two members of the Accelerating Covid-19 Therapeutic Interventions and Vaccines group, or ACTIV, which was organized last month by the National Institutes of Health. The second, they said, involves several vaccine developers working in one large trial — […]